Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings

Pathology International

Volumn 55, Issue 10, 2005, Pages 611-618

  Mizoshita, Tsutomu ^a   Tsukamoto, Tetsuya ^a   Tanaka, Harunari ^a   Takenaka, Yoshiharu ^a   Kato, Sosuke ^a   Cao, Xueyuan ^a   Joh, Takashi ^b   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Carbonic anhydrase 1; Colonic phenotype; Gastric cancers; Small intestinal phenotype; Sucrase

Indexed keywords

CARBONATE DEHYDRATASE I; MUCIN; SUCRASE; VILLIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; AGED; CARBONIC ANHYDRASE I; COLON; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINE, SMALL; LYMPH NODES; MALE; MIDDLE AGED; MUCINS; PHENOTYPE; STOMACH NEOPLASMS; SUCRASE; TUMOR MARKERS, BIOLOGICAL;

EID: 28444486572     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01878.x     Document Type: Article

References (45)

1. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma: An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
2. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gann 1968; 59: 251-8.
3. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn 1982; 32 (Suppl. 2): 329-17.
4. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003; 94: 135-11.
5. Tatematsu M, Furihata C, Katsuyama T et al. Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 1986; 46: 4866-72.
6. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990; 40: 494-504.
7. Tatematsu M, Hasegawa R, Ogawa K et al. Histogenesis of human stomach cancers based on assessment of differentiation. J Clin Gastroenterol 1992; 14 (Suppl. 1): S1-7.
8. Mizoshita T, Tsukamoto T, Nakanishi H et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: Relationship with prognosis. J Cancer Res Clin Oncol 2003; 129: 727-34.
9. Kawachi H, Takizawa T, Eishi Y et al. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol 2003; 199: 436-46.
10. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000; 89: 724-32.
11. Bamba M, Sugihara H, Kushima R et al. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch 2001 ; 438: 49-56.
12. Tajima Y, Shimoda T, Nakanishi Y et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 2001; 61: 212-20.
13. Yamachika T, Inada K, Fujimitsu Y et al. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997; 431: 103-10.
14. Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998; 1: 134-41.
15. Mizoshita T, Inada K, Tsukamoto T et al. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 2004; 130: 29-36.
16. Mizoshita T, Tsukamoto T, Inada K et al. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004; 54: 392-400.
17. Sowden J, Leigh S, Talbot I, Delhanty J, Edwards Y. Expression from the proximal promoter of the carbonic anhydrase 1 gene as a marker for differentiation in colon epithelia. Differentiation 1993; 53: 67-74.
18. Parkkila S, Parkkila AK, Juvonen T, Rajaniemi H. Distribution of the carbonic anhydrase isoenzymes I, II, and Vl in the human alimentary tract. Gut 1994; 35: 646-50.
19. Utsunomiya T, Yonezawa S, Sakamoto H et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients. Clin Cancer Res 1998; 4: 2605-14.
20. Baldus SE, Zirbes TK, Engel S et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas, Int J Cancer 1998; 79: 133-8.
21. Lee HS, Lee HK, Kim HS, Yang HK, Kim Yl, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: Their roles as prognostic indicators. Cancer 2001; 92: 1427-34.
22. Baldus SE, Monig SP, Arkenau V et al. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol 2002; 9: 887-93.
23. Tsuchiya A, Kikuchi Y, Ando Y, Abe R. Correlation between expression of sialosyl-T antigen and survival in patients with gastric cancer. Br J Surg 1995; 82: 960-62.
24. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000; 119: 961-71.
25. Mallo GV, Rechreche H, Frigerio JM et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997; 74: 35-14.
26. Mizoshita T, Inada K, Tsukamoto T et al. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa: With special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 2001; 4: 185-91.
27. Tsukamoto T, Inada K, Tanaka H et al. Down regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/intestinal- mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2004; 130: 135-45.
28. Drummond F, Sowden J, Morrison K, Edwards YH. The caudal-type homeobox protein Cdx-2 binds to the colon promoter of the carbonic anhydrase 1 gene. Eur J Biochem 1996; 236: 670-81.
29. Drummond FJ, Sowden J, Morrison K, Edwards YH. Colon carbonic anhydrase 1: Transactivation of gene expression by the homeodomain protein Cdx2. FEBS Lett 1998; 423: 218-22.
30. Suh E, Chen L, Taylor J, Traber PG. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 1994; 14: 7340-51.
31. Almeida R, Suva E, Santos-Silva F et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003; 199: 36-10.
32. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma: 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
33. Li XL, Eishi Y, Bai YQ et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma, Int J Oncol 2004; 24: 257-63.
34. Tsukamoto T, Mizoshita T, Mihara M et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 2005; 46: 649-58.
35. Yamamoto H, Bai YQ, Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 2003; 300: 813-18.
36. Hinoi T, Tani M, Lucas PC et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001; 159: 2239-48.
37. Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem 2003; 278: 44608-16.
38. Ee HC, Erler T, Bhathal PS, Young GP, James RJ. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995; 147: 586-92.
39. Mallo GV, Soubeyran P, Lissitzky JC et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 1998; 273: 14 030-36.
40. Vider BZ, Zimber A, Hirsch D et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997; 232:742-48.
41. Seno H, Oshima M, Taniguchi MA et al. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications, Int J Oncol 2002; 21: 769-74.
42. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr, Chen LB. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 1993; 105: 820-26.
43. Czernichow B, Simon-Assmann P, Kedinger M et al. Sucrase-isomaltase expression and enterocytic ultrastructure of human colorectal tumors, Int J Cancer 1989; 44: 238-14.
44. Beaulieu JF, Weiser MM, Herrera L, Quaroni A. Detection and characterization of sucrase-isomaltase in adult human colon and in colonie polyps. Gastroenterology 1990; 98: 1467-77.
45. Jessup JM, Lavin PT, Andrews CW Jr et al. Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum 1995; 38: 1257-64.